Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis

E. M. Bordewijk, N. S. Weiss, M. J. Nahuis, N. Bayram, M. H.A. Van Hooff, D. E.S. Boks, D. A.M. Perquin, C. A.H. Janssen, R. J.T. Van Golde, C. B. Lambalk, M. Goddijn, P. G. Hompes, F. Van Der Veen, B. W.J. Mol, M. Van Wely*, J. M.J. Smeenk, A. Hoek, F. J.M. Broekmans, K. Fleischer, J. P. De BruinE. M. Kaaijk, J. S.E. Laven, D. J. Hendriks, M. H. Gerards, P. Bourdrez, J. Gianotten, C. Koks, J. Kwee, A. F. Lambeek, A. F. Van Unnik, F. P.J. Vrouenraets, B. J. Cohlen, T. A.M. Van De Laar-Van Asseldonk, A. W. Nap, J. M. Van Rijn-Van Weert, J. H.A. Vollebergh, N. F. Klijn, H. G.M. Rijnsaardt-Lukassen, A. V. Sluijmer

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences